License U of T Technologies

Who is this for?

Industry and other parties interested in licensing or otherwise using University of Toronto (U of T) technologies.

What do I need before I can begin?

There is no information required to begin. Please reach out to the Director, Innovations at 416-946-5515 if you have questions regarding licensing or using U of T technologies.

Licensing & Technology Opportunities

U of T is a global leader in turning research into products, services, companies and jobs. The Innovations & Partnerships Office (IPO) is your one-stop-shop to license these technologies and innovations from U of T. IPO’s team of licensing professionals make the process as quick and easy as possible.

Use our technology explorer to discover our startups, market-ready innovations, and licensing opportunities, or, contact us to discuss custom solutions.
 

Title Tech Opps Keywords
Novel Counter-Measure Against Nerve Gas & Other Organophosphate/Carbamate Poisoning Advanced Health Technologies , Drug Discovery , Health & Related Life Sciences , molecular mechanisms , Pharmaceutical Research / Manufacturing , Pharmaceuticals , Small Molecules 
Targeting the Hippo Pathway for Cancer & Fibrosis Advanced Health Technologies , Biotechnology , Cancer , Cell Signaling , Drug Discovery , Health & Related Life Sciences , Inflammation , Pharmaceuticals , Small Molecules , Therapeutics 
Inhibition of PKN1 As Therapy For Chronic Lymphocytic Leukemia (CLL) Advanced Health Technologies , Biotechnology , Cancer , Drug Discovery , Health & Related Life Sciences , Leukemia , Pharmaceuticals , Small Molecules , Therapeutics 
A Multi-Targeting CRISPR-Cas System for Systematic and Combinatorial Genetic Perturbation Advanced Health Technologies , Drug Discovery , Functional Genomics , Gene Editing , Gene Expression , Genetics , Health & Related Life Sciences , molecular mechanisms , Pharmaceutical Research / Manufacturing , Pharmaceuticals , Research Tools 
Boron Containing Bioactive Biomolecules Chemical Synthesis , Drug Discovery , Health & Related Life Sciences , Pharmaceuticals , Small Molecules , Therapeutics 
CRISPR-Based Screening Platform Technology for Drug Discovery Biotechnology , Cell Signaling , CRISPR , Drug Discovery , Functional Proteomics , Health & Related Life Sciences , Membrane Proteins , Pharmaceutical Research / Manufacturing , Protein-Protein Interactions 
Cryosparc: Accelerated Protein Structure Determination from Cryo-EM 3D imaging , Advanced Health Technologies , Artificial Intelligence (AI) , Companies , Drug Discovery , Electron Microscopy , Machine Learning , Pharmaceutical Research / Manufacturing , Pharmaceuticals , Proteins , Research Tools , Software 
Mammalian Membrane Two-Hybrid (MaMTH) Technology: a Novel Protein Interaction and Drug Discovery Tool Cancer , Cell Signaling , Disease Detection , Drug Discovery , Genetics , Membrane Proteins , Neurological Disorders , Protein-Protein Interactions , Proteins 
Oxadiazole-Containing Cyclic Peptides Chemical Synthesis , Drug Discovery , Peptides 
UBA5 Inhibitors for the Treatment of Cancer and Leishmaniasis Cancer , Disease Detection , Drug Discovery , Leukemia , Multiple Myeloma 

VPRI Role

  • Market U of T technologies to industry
  • Negotiate license agreements with interested companies
  • Assist in finding partners and funding to support proof-of-concept and commercialization
  • Support long-term relationships with strategic partners that help develop early-stage discoveries into market-ready technologies and products

VPRI Contact

Staff

Jennifer Fraser

Director, Innovations
Innovations & Partnerships Office (IPO)
(416) 946-5515
Radio Options- Did you find this useful?
Did you find this useful?
Let us know if you found this page useful. Did you find the information you were looking for?